Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLRO
CLRO logo

CLRO Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
16.500
Open
9.590
VWAP
12.82
Vol
83.75M
Mkt Cap
37.03M
Low
8.130
Amount
1.07B
EV/EBITDA(TTM)
--
Total Shares
2.68M
EV
17.97M
EV/OCF(TTM)
--
P/S(TTM)
--
ClearOne, Inc. is a global market company enabling conference, collaboration, and network streaming solutions. The Company designs, develops and sells conferencing, collaboration, and AV networking solutions for voice and visual communications. Its product categories include audio-conferencing, including installed DSP-based professional audio conferencing and USB-based speakerphones; professional microphones consisting of patented beamforming microphone arrays, ceiling microphones and wireless microphones, and video, including video collaboration and AV networking products. Its audio-conferencing products feature its proprietary HDConference, Distributed Echo Cancellation and noise cancellation technologies to enhance communication during a conference call by eliminating echo and background noise. Its professional conferencing products include the CONVERGE Pro 2 and CONVERGE Pro 2 SR product lines. Its premium conferencing offering consists of the CONVERGE Huddle product line.
Show More

Events Timeline

(ET)
2026-07-07
10:00:00
ClearOne Trading Halted Due to Volatility
select
2026-07-02 (ET)
2026-07-02
08:30:00
Vivani Medical Enters Merger Agreement with ClearOne
select
2026-07-02
08:30:00
ClearOne Enters Merger Agreement with Vivani Medical
select
2026-06-25 (ET)
2026-06-25
06:30:00
ClearOne Files $50M Mixed Securities Shelf
select
2026-02-03 (ET)
2026-02-03
16:10:00
ClearOne Trading Resumes
select
2026-02-03
16:00:00
ClearOne Trading Halted Due to Volatility
select
2026-01-13 (ET)
2026-01-13
13:10:00
ClearOne Trading Halted Due to Volatility
select
2025-10-27 (ET)
2025-10-27
09:33:50
ClearOne Completes Asset Sale to Biamp Systems
select

News

stocktwits
8.5
07-02stocktwits
ClearOne's Strategic Shift and Merger with Cortigent
  • Strategic Pivot: ClearOne divested its legacy assets to Biamp in October last year, successfully pivoting into the medical technology sector, with former shareholders retaining approximately 12.7% to 14.4% of the new entity, indicating potential in the new market.
  • Reverse Merger Agreement: The announcement of a reverse merger with Cortigent, a unit of Vivani Medical, led to a more than 170% surge in CLRO stock, reflecting strong market recognition and investor optimism regarding the new business model.
  • Terms of the Deal: Under the agreement, Vivani will receive 12.5 million shares of ClearOne, gaining control of 59.4% to 67.5% of the combined entity, with Cortigent becoming the surviving entity, marking a new beginning for ClearOne in the medical technology field.
  • Funding Plan: ClearOne aims to raise up to $15 million concurrently with the deal's closing, providing a strong foundation for the combined company to advance its product pipeline and further solidify its market position.
seekingalpha
8.5
07-02seekingalpha
ClearOne Signs Merger Agreement to Acquire Cortigent
  • Merger Agreement: ClearOne announced the signing of a definitive merger agreement to acquire Cortigent, a unit of Vivani Medical, which will become a wholly owned subsidiary post-transaction, enhancing ClearOne's competitive position in the market.
  • Funding Strategy: The company plans to raise $10 million to $15 million through Form S-1 financing alongside the transaction closing, with these funds expected to support the combined company's pipeline development and ensure ongoing technological innovation.
  • Technological Edge: Cortigent's neurostimulation technology aims to assist patients in recovering sight and motor function, addressing significant unmet medical needs, which is anticipated to provide ClearOne with new growth opportunities and market expansion.
  • Management Outlook: ClearOne Chairman Eric Robinson emphasized that this acquisition will help address critical health issues for patients, further solidifying the company's strategic position in the medical technology sector.
NASDAQ.COM
8.5
07-02NASDAQ.COM
Vivani Medical Merges with ClearOne to Form Cortigent Holdings
  • Merger Announcement: Vivani Medical's wholly owned subsidiary Cortigent is merging with ClearOne, with Cortigent becoming a wholly owned subsidiary and rebranding as Cortigent Holdings, which is set to list on Nasdaq, marking a significant milestone for Cortigent as an independent public entity.
  • Financing Plan: ClearOne aims to raise between $10 million and $15 million through concurrent financing, which will provide essential funding for the development of Cortigent's neurostimulation technologies, particularly in vision restoration and stroke recovery devices, thereby accelerating its technological advancements.
  • Equity Structure Changes: Post-merger, Vivani will receive 12.5 million shares of ClearOne common stock, expected to hold 59.4% to 67.5% of the combined entity, while former ClearOne shareholders will retain 12.7% to 14.4%, indicating Vivani's significant control in the merged company.
  • Market Performance: ClearOne's stock has traded between $2.71 and $12.25 over the past year, currently priced at $3.70, reflecting a 14.91% increase, indicating a positive market reaction to the merger news.
Newsfilter
8.5
2025-10-27Newsfilter
ClearOne Confirms Completion of Asset Sale Deal
  • Asset Sale Announcement: ClearOne, Inc. has entered into a definitive agreement to sell certain assets to Biamp Systems, which includes intellectual property, product inventory, and customer data, as part of its strategic plan to potentially sell all or most of its assets.

  • Exclusions from Sale: The sale excludes ClearOne's parent company records, equity of sellers, and product warranty and support operations, which ClearOne will continue to manage.

  • Public Company Status: ClearOne will remain a public company post-sale, with CEO Derek Graham stating that the transaction aims to maximize shareholder value and enable new business opportunities.

  • Company Background: ClearOne is known for its conferencing and audio-visual technology solutions, serving global integrators and end-users to enhance communication experiences.

NASDAQ.COM
2.0
2025-08-18NASDAQ.COM
Premarket Stock Movements: PPCB, BTAI, TNXP, DAY, TPIC, and Other Notable Gainers and Losers
  • Premarket Trading Activity: Notable activity is observed in premarket trading as of 6.50 a.m. ET on Monday, indicating potential opportunities before the market opens.

  • Importance for Traders: Premarket trading allows active traders to identify possible breakouts, reversals, or price swings, making it crucial for analyzing momentum heading into the regular session.

  • Stocks Performance: Some stocks are showing significant percentage increases while others are experiencing notable declines during Monday's premarket session.

  • Author's Perspective: The views expressed in the article reflect the author's opinions and do not necessarily represent those of Nasdaq, Inc.

Benzinga
8.0
2025-07-01Benzinga
ClearOne (CLRO) Stock Is Soaring Tuesday: Here's Why
  • ClearOne Announces Special Dividend: ClearOne Inc. will issue a one-time special stock dividend of Class A Redeemable Preferred Stock for each outstanding share of common stock, linked to potential asset sales, with payment scheduled for July 18.

  • Stock Price Surge: Following the announcement, ClearOne's shares have increased significantly, trading 93.9% higher at $11.15.

Valuation Metrics

The current forward P/E ratio for Clearone Inc (CLRO.O) is 123.46, compared to its 5-year average forward P/E of 32.76. For a more detailed relative valuation and DCF analysis to assess Clearone Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
32.76
Current PE
123.46
Overvalued PE
77.39
Undervalued PE
-11.87

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
2.35
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
5.27
Undervalued EV/EBITDA
-0.57

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.49
Current PS
0.00
Overvalued PS
0.76
Undervalued PS
0.22

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks to swingmax trading for today
Intellectia · 65 candidates
Region: USRelative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5, PriceAboveMA20, PriceCrossAboveMA5, PriceCrossAboveMA20Week Price Change Pct: >= $0.00Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CLRO logo
CLRO
Clearone Inc
18.73M
ZCMD logo
ZCMD
Zhongchao Inc
92.84K
LUCY logo
LUCY
Innovative Eyewear Inc
7.94M
WBX logo
WBX
Wallbox NV
96.40M
SBEV logo
SBEV
Splash Beverage Group Inc
3.36M
SEER logo
SEER
Seer Inc
120.41M

Whales Holding CLRO

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Clearone Inc (CLRO) stock price today?

The current price of CLRO is 13.84 USD — it has increased 97.71

What is Clearone Inc (CLRO)'s business?

ClearOne, Inc. is a global market company enabling conference, collaboration, and network streaming solutions. The Company designs, develops and sells conferencing, collaboration, and AV networking solutions for voice and visual communications. Its product categories include audio-conferencing, including installed DSP-based professional audio conferencing and USB-based speakerphones; professional microphones consisting of patented beamforming microphone arrays, ceiling microphones and wireless microphones, and video, including video collaboration and AV networking products. Its audio-conferencing products feature its proprietary HDConference, Distributed Echo Cancellation and noise cancellation technologies to enhance communication during a conference call by eliminating echo and background noise. Its professional conferencing products include the CONVERGE Pro 2 and CONVERGE Pro 2 SR product lines. Its premium conferencing offering consists of the CONVERGE Huddle product line.

What is the price predicton of CLRO Stock?

Wall Street analysts forecast CLRO stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLRO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Clearone Inc (CLRO)'s revenue for the last quarter?

Clearone Inc revenue for the last quarter amounts to 0.00 USD, decreased

What is Clearone Inc (CLRO)'s earnings per share (EPS) for the last quarter?

Clearone Inc. EPS for the last quarter amounts to -0.20 USD, decreased -88.37

How many employees does Clearone Inc (CLRO). have?

Clearone Inc (CLRO) has 80 emplpoyees as of July 08 2026.

What is Clearone Inc (CLRO) market cap?

Today CLRO has the market capitalization of 37.03M USD.